Transdermal fentanyl patches first became available in the early 1990s and provided an
innovative treatment for the management of cancer pain. Since then, they have become a …

The management of pain is complex having to take into consideration patient specific
characteristics. Drug therapy should be individualized and managed based on numerous …

Transdermal (TTS) fentanyl therapy has emerged as an effective alternative to the use of
oral opioids for the control of pain in certain cancer patients. These patients are those with …

Fentanyl has been incorporated into a transdermal therapeutic system (TTS) containing a
rate-limiting membrane that provides constant release of the opioid. TTS fentanyl provides …

Transdermal fentanyl offers the advantage of providing continuous administration of a potent
opioid in the absence of needles and expensive drug-infusion pumps for the treatment of …

BA CKGROUND: Transdermal therapeutic systems offer potential advantages over oral or
intravenous routes of drug administration. The purpose of this prospective study was to …

Background Initial treatment with morphine followed by fentanyl transdermal patch is the
standard in Japan, since even the smallest patch (2.5 mg) could deliver too high an initial …

Background: Different opioids for use in the control of moderate to severe cancer pain have
become widely available. More recently, sophisticated formulations such as transdermal …

Over the last 20 years, orally administered opioids have become the standard
pharmacological treatment for moderate to severe cancer pain (1). In most patients, pain can …

A multicenter study was conducted to determine the patient and physician acceptability of
transdermal fentanyl in the management of cancer-related pain. In this study, 10 cancer …